Therefore, in this study, we further explored the mechanism of IC2-induced anti-breast cancer effect in vitro and in vivo, and we demonstrated that IC2 mediated cytoprotective autophagy in breast cancer cells through SCD1 inhibition, which provided a promising strategy for clinicians to explore the treatment of breast cancer. Here, SCD is linked to breast cancer.